N'-[[5-Fluoro-2-hydroxy-3-(2-propenyl)phenyl]methylene]-4-[(4-fluorophenyl)methyl]-1-piperazineacetohydrazide

ID: ALA3426432

Chembl Id: CHEMBL3426432

PubChem CID: 136510222

Max Phase: Preclinical

Molecular Formula: C23H26F2N4O2

Molecular Weight: 428.48

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C=CCc1cc(F)cc(/C=N/NC(=O)CN2CCN(Cc3ccc(F)cc3)CC2)c1O

Standard InChI:  InChI=1S/C23H26F2N4O2/c1-2-3-18-12-21(25)13-19(23(18)31)14-26-27-22(30)16-29-10-8-28(9-11-29)15-17-4-6-20(24)7-5-17/h2,4-7,12-14,31H,1,3,8-11,15-16H2,(H,27,30)/b26-14+

Standard InChI Key:  LJBHSPWBMJCSSS-VULFUBBASA-N

Alternative Forms

1. Parent:

   

   ALA3426432

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 428.48

Molecular Weight (Monoisotopic): 428.2024

AlogP: 2.67

#Rotatable Bonds: 8

Polar Surface Area: 68.17

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.31

CX Basic pKa: 6.48

CX LogP: 3.51

CX LogD: 3.55

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.39

Np Likeness Score: -1.57

References

1. Roth HS, Botham RC, Schmid SC, Fan TM, Dirikolu L, Hergenrother PJ..  (2015)  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.,  58  (9): [PMID:25856364] [10.1021/acs.jmedchem.5b00413]

Source

Source(1):

• Scientific Literature